language
When will the COVID-19 vaccine be available? How much will it cost? Here’s the official response!
Release time:
2020-09-28
Source:
On September 25, the State Council Information Office held a briefing attended by officials from the Ministry of Science and Technology, the National Health Commission, and the National Medical Products Administration, as well as relevant experts, to provide an update on the progress of COVID-19 vaccine development.
Wu Yuanbin, Director of the Department of Social Development Science and Technology at the Ministry of Science and Technology At present, 11 COVID-19 vaccines in China have entered the clinical research phase, with 3 inactivated vaccines and 1 adenovirus‑vector vaccine already in Phase III clinical trials. Other recombinant protein vaccines, mRNA vaccines, and live attenuated influenza virus‑vector vaccines are being rapidly advanced through Phase I/II clinical trials. The four vaccines currently in Phase III clinical trials are progressing smoothly.
2. When will China’s COVID-19 vaccines be approved for market?
Yang Sheng, Head of the Drug Registration Management Division of the National Medical Products Administration Before a vaccine can be launched, it must first complete preclinical studies and Phase I and Phase II clinical trials, and then pass Phase III clinical trials to demonstrate that the vaccine’s safety and efficacy meet the established standards. In addition, commercial-scale validation must be carried out to confirm that the vaccine intended for market launch meets acceptable safety standards, exhibits clear efficacy, and maintains controllable quality.
The pace of Phase III clinical trials is influenced by numerous factors, such as the number of participants, the number of participant groups, and the trial outcomes. Researchers will adopt a case‑by‑case approach to accelerate the timely launch of COVID-19 vaccines in China.
3. How long does the COVID-19 vaccine provide protection?
Zeng Guang, Chief Scientist of Epidemiology at the Chinese Center for Disease Control and Prevention Humans have only discovered the novel coronavirus nine months ago, and determining how long protection lasts after each vaccine is administered still requires extensive, long‑term research.
Currently, serological monitoring of the earliest vaccinated subjects in China shows that antibody levels remain relatively high, suggesting that the vaccine may provide relatively long‑term protection.
4. How many COVID-19 vaccines will China produce?
Zheng Zhongwei, Head of the Special Task Force on Vaccine Research and Development within the Scientific Research Task Force. According to estimates, China’s annual vaccine production capacity is expected to reach 610 million doses by the end of this year, and more than 1 billion doses next year.
We divide the population into three categories:
In the future, vaccinations will be administered in the order of high‑risk populations, high‑danger populations, and the general population.
5. How will China’s COVID-19 vaccines be priced?
Zheng Zhongwei, Head of the Special Task Force on Vaccine Development within the Scientific Research Task Force. The pricing of COVID-19 vaccines in China will adhere to their status as public goods, ensuring both accessibility and affordability—and will certainly remain within a range that the general public can accept.
6. Do I still need to wear a mask after getting vaccinated?
Zeng Guang, Chief Scientist of Epidemiology at the Chinese Center for Disease Control and Prevention This winter and spring, in addition to COVID-19, we will also have to contend with influenza, adenovirus, and other respiratory infectious diseases—and no COVID‑19 vaccine can be said to be 100% effective. More importantly, for most people, it may not be possible to get vaccinated this winter or next spring.
Therefore, whether or not to wear a mask should be determined based on the local COVID-19 epidemic situation, the prevalence of other respiratory infectious diseases, ventilation conditions, and one’s own immune status. In particular, older adults, patients with chronic illnesses, and children should take extra precautions. In addition, we recommend that everyone continue to practice good habits such as wearing masks, washing hands frequently, and maintaining social distance.
Keywords:
When will the COVID-19 vaccine be available? How much will it cost? Here’s the official response!
Related News
Chengdu Hengbo Medical Device Co., Ltd.
-
Address: 7th Floor, Pusheng Building, No. 10, East 4th Section, First Ring Road, Chengdu
Sales Hotline:+86-28-84446318 +86-28-84432673
After-sales Service Hotline:+86-400-6686-948 +86-28-84446327Complaint hotline:+86-13808079011
Email:chinahbyj@163.com
After sale
Applets
Copyright: Chengdu Hengbo Medical Device Co., Ltd.
Internet Drug Information Service Qualification Certificate" No.: (Sichuan)-Non-operating-2012-0010
This website does not publish product information for narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug addiction treatment drugs, or preparations formulated by medical institutions.
hengboyiliao
huanhuanhall
Global Servlce Hotline：+86-400-6686-948
Sales Hotline：+86-13308065831
Sales Hotline：+86-28-84446318
After-Sales Hotline：+86-28-84446327
Complaint Hotline：+86-13808079011
Emall：hengbomedical@163.com